Insulin Access for All Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jan 9, 2019)
Insulin Access for All Act of 2019
This bill prohibits cost-sharing (e.g., copayments) under Medicaid and the Medicare prescription drug benefit for insulin and associated medical supplies.
What just happenedMar 1, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJan 9, 2019
- Mar 1, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 25, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 9, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jan 9, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jan 9, 2019IntroReferralIntro-H
Introduced in House
- Jan 9, 2019IntroReferral1000
Introduced in House